[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 21, Issue 1 (Bimonthly 2017) ::
Feyz 2017, 21(1): 28-34 Back to browse issues page
Evaluation of anticancer peptide VEGF111b secretion in HEK293 human cells
Morteza Sadeghi *, Zohreh Hojati
Human Genetic Research Center, Baqiyatallah Medical Sciences University, Tehran, I. R. Iran. , ms.sadeghi@yahoo.com
Abstract:   (1305 Views)

Background: VEGF111b is a new isoform of vascular endothelial growth factor (VEGF) recently considered as a new anticancer drug. The aim of this study was to evaluate the VEGF111b secretion from HEK293 cell wall in order to commercial production of this recombinant factor.

Materials and Methods: After the design of VEGF111b sequence using OLIGO software and NCBI gene bank data, it was cloned into the pBUD.cE4.1 vector. The pBUD.VEGF111b recombinant vector was transfected into HEK293 cells using lipofectamine kit. Forty-eight hours after the transfection the production of VEGF111b was estimated by Western blotting and Human anti VEGF antibody. The VEGF111b secretion   into cell culture and cell lysate extract was measured using ELISA.  

Results: The correct cloning of VEGF111b into pBUD.cE4.1vector was confirmed using enzymatic digestion and gel electrophoresis. The observed production of recombinant peptide in HEK293 was confirmed with 12KDa band in cell lysate extract of Western blotting. The ELISA results at 450 nanometer absorbance for cell culture media and cell lysate extract were 19.20±2.81 pg/ml and 32.87±7.42 pg/ml, respectively. However, no VEGF111b expression was observed in negative controls.

Conclusion: The findings of this study indicate the powerful ability of   transformation and secretion of VEGF111b from HEK293 cell  wall to cell culture media with no breaking and proteolytic digestion. It seems that the commercial production and purification of this therapeutic peptide from HEK293 cell culture would be possible with high efficiency.

Keywords: Vascular Endothelial Growth Factor A, Secretion, HEK293
Full-Text [PDF 338 kb]   (417 Downloads)    
Type of Study: Research | Subject: General
Received: 2017/02/26 | Accepted: 2017/02/26 | Published: 2017/02/26
1. Makrilia N, Lappa T, Xyla V, Nikolaidis I, Syrigos K. The role of angiogenesis in solid tumors: an over-view. Eur J Intern Med 2009; 20(7): 663-71.
2. Drevs J. VEGF and angiogenesis: imlications for breast cancer therapy. EJC Supplements 2008; 6: 7-13.
3. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 2001; 33(4): 409–20.
4. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62(14): 4123–31.
5. Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, et al. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term. Clin Sci (Lond) 2006; 110(5): 575 –85.
6. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to the human chromosome 6p21.3. Circulation 1996; 93(8): 1493–5.
7. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal trans‌duction by vascular endothelial growth factor receptors. Biochem J 2011; 437(2): 169–83.
8. Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol 2012; 24(2): 188–93.
9. Carmeliet P, Ruiz de Almodovar C. VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cell Mol Life Sci 2013; 70(10): 1763–78.
10. Huez I, Bornes S, Bresson D, Creancier L, Prats H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001; 15(12): 2197–210.
11. Meiron M, Anunu R, Scheinman EJ, Hashmueli S, Levi BZ. New isoforms of VEGF are translated from alternative initiation CUG codons located in its 5’UTR. Biochem Biophys Res Commun 2001; 282(4): 1053–60.
12. Tee MK, Jaffe RB. A precursor form of vascular endothelial growth factor arises by initiation from an upstream in-frame CUG codon. Bio‌chem J 2001; 359 (Pt 1): 219–26.
13. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regula‌tion of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267(36): 26031–7.
14. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002; 16(20): 2684–98.
15. Gu F, Li X, Kong J, Pan B, Sun M, Zheng L, et al. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis. Biochem Biophys Res Commun 2013; 441(1): 18–24
16. Dvorak HF. VPF/VEGF and the angiogenic response. Semin Perinatol 2000; 24(1): 75–8.
17. Raab S, Plate KH. Different networks, common growth factors: shared growth factors and receptors of the vascular and nervous system. Acta Neuropathol 2007; 113(6): 607-26.
18. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under phisiological and pathological conditions. Clin Sci 2005; 109(3): 227-41.
19. Emamgholipour S, Bandehpour M, Shabani P, Maghen L, Yaghmaee B, Kazemi B. Mutagenesis in se-quence encoding of human factor VII for gene therapy of hemophilia. DARU 2009; 17(4): 294-8.
20. Rennel E, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, et al. The endogenous antiangiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer 2008; 98(7): 1250–7.
21. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, Yuce A, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109(3): 327–36.
22. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008; 4(4): 241–6.
23. von Degenfeld G, Banfi A, Springer ML, Wagner RA, Jacobi J, Ozawa CR, et al. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J 2006; 20(14): 2657–9.
24. Kerbel RS. Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000; 21(3): 505-15.
25. Walter DH1, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, et al. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Lab Invest 1996; 74(2): 546–56.
26. Chen E, Hermanson S, Ekker SC. Syndecan-2 is essential for angio‌genic sprouting during zebrafish development. Blood 2004; 103(5): 1710–9.
27. Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, et al. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 2006; 99(8): 853–60.
28. Krilleke D, DeErkenez A, Schubert W, Giri I, Robinson GS, Ng YS, et al. Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J Biol Chem 2007; 282(38): 28045–56.
29. Ruiz de AC, Coulon C, Salin PA, Knevels E, Chounlamountri N, Poesen K. Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1. J Neurosci 2010; 30(45): 15052–66.
30. Chen S, Chakrabarti R, Keats EC, Chen M, Chakrabarti S, Khan ZA. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells. Invest Ophthalmol Vis Sci 2012; 53(13): 8333–43.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sadeghi M, Hojati Z. Evaluation of anticancer peptide VEGF111b secretion in HEK293 human cells. Feyz. 2017; 21 (1) :28-34
URL: http://feyz.kaums.ac.ir/article-1-3277-en.html

Volume 21, Issue 1 (Bimonthly 2017) Back to browse issues page
مجله علمی پژوهشی فیض ::: دانشگاه علوم پزشکی کاشان KAUMS Journal ( FEYZ )
Persian site map - English site map - Created in 0.08 seconds with 32 queries by YEKTAWEB 3921